A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients

Completed

Phase 2 Results

Summary of Purpose

This study will investigate the effects of a potential neuroprotectant compound, YM872, in the treatment of acute ischemic stroke. The study will determine if a 24-hour infusion of YM872, given within 6 hours of stroke onset, reduces the ischemic lesion volume as measured by MRI at 28 days after the infusion is given. The clinical effects of YM872 will also be determined by neurological function and disability...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 March 2006.

1 Dec 2000 16 Aug 2002 Unavailable 1 Jan 2003 1 Mar 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment

Contacts

  • Karin Yurko-Mauro, PhD Cato Research Washington 9850 Key West Avenue, Suite 400 Rockville, Maryland 20850-3919

    wlong@mail.cato.com